ClinicalTrials.Veeva

Menu

Comparison of Dydrogesterone and Micronized Progesterone Treatments in the Treatment of Threatened Miscarriage.

K

Konya Meram State Hospital

Status and phase

Not yet enrolling
Phase 4

Conditions

Miscarriage Threatening

Treatments

Drug: Duphastone

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

In this study, we aimed to compare the effects of two drugs used for the threated miscarriage on the miscarriage rate.

Full description

About 140 pregnant women who applied to our clinic due to the threated miscarriage in the first trimester will be randomly given micronized progesterone to half and dydrogesterone to the other half. After the treatment, the miscarriage rates in the groups will be compared.

Enrollment

140 estimated patients

Sex

Female

Ages

18 to 30 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • pregnant women with threated miscarriage in the first trimester.

Exclusion criteria

    • pregnant women with abortus incipiens.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

140 participants in 2 patient groups

Micronised progesterone
Experimental group
Description:
Micronized progesterone will be given to 70 pregnant women with threated miscarriage.
Treatment:
Drug: Duphastone
Dydrogesterone
Experimental group
Description:
Dydrogesterone will be given to 70 pregnant women with threated miscarriage.
Treatment:
Drug: Duphastone

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems